Association of ischaemic stroke subtype with long-term cardiovascular events

European Journal of Neurology

Volumn 21, Issue 8, 2014, Pages 1108-1114

  Ntaios, G ^a   Papavasileiou, V ^a   Makaritsis, K ^a   Milionis, H ^b   Michel, P ^c   Vemmos, K ^d  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d Hellenic Cardiovascular Research Society   (Greece)

Author keywords

Cardiovascular risk; Coronary heart disease; Ischaemic stroke; Stroke subtypes

Indexed keywords

ACUTE HEART FAILURE; ANEURYSM RUPTURE; ANGINA PECTORIS; AORTA ANEURYSM; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BRAIN FUNCTION; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; FOLLOW UP; HEART INFARCTION; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; SUDDEN CARDIAC DEATH; CARDIOVASCULAR DISEASES; CLASSIFICATION; GREECE; MORTALITY; REGISTER; RISK; STROKE;

BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; FOLLOW-UP STUDIES; GREECE; HUMANS; RECURRENCE; REGISTRIES; RISK; STROKE;

EID: 84903991031     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12438     Document Type: Article

References (18)

1. National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl. 1): S1-S266.
2. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
3. Lackland DT, Elkind MS, D'Agostino R Sr, et al. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012; 43: 1998-2027.
4. British Cardiac S, British Hypertension S, Diabetes UK, Heart UK, Primary Care Cardiovascular S, Stroke A. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91(Suppl. 5): v1-v52.
5. Dhamoon MS, Elkind MS. Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease. Circulation 2010; 121: 2071-2078.
6. Vemmos KN, Takis CE, Georgilis K, et al. The Athens stroke registry: results of a five-year hospital-based study. Cerebrovasc Dis 2000; 10: 133-141.
7. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976; 54: 541-553.
8. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
9. Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 2005; 36: 2748-2755.
10. Dhamoon MS, Tai W, Boden-Albala B, et al. Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke 2007; 38: 1752-1758.
11. Ois A, Cuadrado-Godia E, Rodriguez-Campello A, et al. Relevance of stroke subtype in vascular risk prediction. Neurology 2013; 81: 575-580.
12. Jackson C, Sudlow C. Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain 2005; 128(Pt 11): 2507-2517.
13. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001; 32: 2735-2740.
14. Mohan KM, Crichton SL, Grieve AP, Rudd AG, Wolfe CD, Heuschmann PU. Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register. J Neurol Neurosurg Psychiatry 2009; 80: 1012-1018.
15. Amarenco P, Benavente O, Goldstein LB, et al. Results of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial by stroke subtypes. Stroke 2009; 40: 1405-1409.
16. van Latum JC, Koudstaal PJ, Venables GS, van Gijn J, Kappelle LJ, Algra A. Predictors of major vascular events in patients with a transient ischemic attack or minor ischemic stroke and with nonrheumatic atrial fibrillation. European Atrial Fibrillation Trial (EAFT) Study Group. Stroke 1995; 26: 801-806.
17. Barba A, Vega de Ceniga M, Estallo L, Fuente ND, Viviens B, Izagirre M. Prevalence of abdominal aortic aneurysm is still high in certain areas of southern Europe. Ann Vasc Surg 2013; 27: 1068-1073.
18. Ntaios G, Papavasileiou V, Diener HC, Makaritsis K, Michel P. Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials. Stroke 2012; 43: 3298-3304.